Skip to Main Navigation Skip to Page Content

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Target Organs and Levels of Evidence for TR-479

Toxicology and Carcinogenesis Studies of Coconut Oil Acid Diethanolamine Condensate (CASRN 68603-42-9) in F344/N Rats and B6C3F1 Mice (Dermal Studies)

Chemical (Study Title) CASRN	Peer Review Date	Route/Exposure Levels	Study Laboratory
Coconut oil acid diethanolamine condensate 68603-42-9	12/10/1997	Topical Application R: 0, 50, or 100 mg/kg M: 0, 100, or 200 mg/kg (50 sex/species/group)	Battelle Columbus Laboratory

Levels of Evidence

Male Rats: No Evidence

Type	Organ/Tissue (Lesion)
Non-Neoplastic Lesions	Skin: epidermal hyperplasia; sebaceous gland hyperplasia; parakeratosis; hyperkeratosis

Female Rats: Equivocal Evidence

Type	Organ/Tissue (Lesion)
May Have Been Related	Kidney Tubular Cell: adenoma or carcinoma (standard evaluation 0/50, 2/50, 0/50; standard and extended evaluations combined 0/50, 4/50, 1/50)
Non-Neoplastic Lesions	Skin: epidermal hyperplasia; sebaceous gland hyperplasia; parakeratosis; hyperkeratosis Forestomach: chronic active inflammation; epithelial hyperplasia; epithelial ulcer
	Kidney: severity of nephropathy

Male Mice: Clear Evidence

Type	Organ/Tissue (Lesion)
Neoplastic Lesions	Liver: adenoma 22/50, 35/50, 45/50; hepatoblastoma 1/50, 1/50, 10/50; hepatocellular adenoma, carcinoma, or hepatoblastoma 29/50, 39/50, 49/50 Kidney Tubular Cell: adenoma 1/50, 1/50, 7/50; renal tubule adenoma or carcinoma 1/50, 1/50, 9/50
Non-Neoplastic Lesions	Liver: eosinophilic foci Skin: epidermal hyperplasia; sebaceous gland hyperplasia; hyperkeratosis; ulcer Thyroid gland: follicular cell hyperplasia

Female Mice: Clear Evidence

Type	Organ/Tissue (Lesion)
Neoplastic Lesions	Liver: adenoma 32/50, 44/50, 43/50; hepatocellular carcinoma 3/50, 21/50, 32/50; hepatocellular adenoma, carcinoma, or hepatoblastoma 33/50, 46/50, 48/50
Non-Neoplastic Lesions	Skin: epidermal hyperplasia; sebaceous gland hyperplasia; hyperkeratosis; chronic active inflammation; parakeratosis Thyroid gland: follicular cell hyperplasia